ENDRA Life Sciences- Warrants (12/05/2022) Long Term Debt

ENDRA Life Sciences- Warrants (12/05/2022) (NDRAW) currently reports a long-term debt of $330K as of March 2026. That compares with $460K in the prior-year period — down 29.0% year over year. Use the charts on this page to explore ENDRA Life Sciences- Warrants (12/05/2022)'s long-term debt history and peer comparisons.

ENDRA Life Sciences- Warrants (12/05/2022)'s long-term debt decreased from $460K to $330K — a 29.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ENDRA Life Sciences- Warrants (12/05/2022) reported $330K in long-term debt as of March 2026. That compares with $460K in the prior-year period — down 29.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $330K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ENDRA Life Sciences- Warrants (12/05/2022), and consider following NDRAW for alerts when major investors trade the stock.

ENDRA Life Sciences- Warrants (12/05/2022) is classified in the Technology sector. On long-term debt, it currently shows $330K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NDRAW with unrelated industries.